Middle East and Africa Cosmeceuticals Research Report 2023-2033: Demographic Shift and Youthful Population Propel Demand, Social Media and Beauty Trends Influence Surge
DUBLIN, March 13, 2024 /PRNewswire/ — The “Middle East and Africa Cosmeceuticals Market – A Regional and Country Level Analysis, 2023-2033″ report has been added to ResearchAndMarkets.com’s offering. The Middle East and Africa (MEA) cosmeceuticals market is experienci
Study shows improved hand function using Carbonhand
STOCKHOLM, March 13, 2024 /PRNewswire/ — Today, a study on Improved physical function using a power-enhancing glove in persons with Inclusion Body Myositis was presented at the Global Conference on Myositis in Pittsburgh, USA. The preliminary results show increased hand function and improved p
UK Ammonia Crackers Industry Research 2023-2032: Increasing Adoption of Green Hydrogen into Mobility Sector and Government Initiatives for Net-Zero Emission Presents Lucrative Opportunities
DUBLIN, March 13, 2024 /PRNewswire/ — The “U.K. Ammonia Crackers Market – Analysis and Forecast, 2023-2032” report has been added to ResearchAndMarkets.com’s offering. The U.K. ammonia crackers market is projected to reach $19.34 million by 2032 from $2.77 million i
DRUID Announces Martin Kraft as New Vice President of Sales for EMEA & APAC Regions
LONDON, March 14, 2024 /PRNewswire/ — DRUID, a leading provider of innovative technology solutions, is thrilled to announce that Martin Kraft has been appointed as the new Vice President of Sales for the EMEA and APAC regions. With a distinguished career spanning several years in the technolo
Pharmaceutical and Biotechnology Royalty Rates Report 2024: Essential Benchmark Data for Dealmakers – Royalty Rates, Deal Financials, Contract Documents, Royalty Rate Trends
DUBLIN, March 13, 2024 /PRNewswire/ — The “Royalty Rates in Pharmaceutical and Biotechnology Deals” report has been added to ResearchAndMarkets.com’s offering. Royalty Rates in Pharmaceutical and Biotechnology Deals is your one-stop source for providing real-deal informatio
Asep Medical Confirms the Use of AI – Enables Improved Treatments for Common Biofilm Infections and Rapid Sepsis Diagnostics
VANCOUVER, BC, March 13, 2024 /PRNewswire/ – In a recent presentation to the US Biophysical Society in Philadelphia1, Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) CEO Dr. Bob Hancock announced how the ground-breaking u
Global Pharmaceuticals and Biotechnology Asset Purchase Deal Analysis Report 2024: Key Trends of Business Assets, Product Assets, Royalty Assets, and Technology Assets Deals Signed Since 2016
DUBLIN, March 13, 2024 /PRNewswire/ — The “Asset Purchase Deals in Pharmaceuticals and Biotechnology 2016-2024” report has been added to ResearchAndMarkets.com’s offering. Asset Purchase Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analys
Dynata vigorously refutes Moody’s factual inaccuracies and misclassification of credit rating
SHELTON, Conn., March 13, 2024 /PRNewswire/ — Dynata — the most trusted source for reliable, accurate first-party data — with the support of its lenders, has confirmed the termination of its ratings arrangement with Moody’s effective March 8. Notwithstanding such termination, Moody&
USI Introduces Innovative 150KW Power Module for xEVs Traction Inverters
SHANGHAI, March 14, 2024 /PRNewswire/ — USI (SSE: 601231), a global leader in electronic design and manufacturing, its Power Module Team proudly announces its groundbreaking Joint Design Manufacturer (JDM) project aimed at developing a cutting-edge 150KW power module named “Magnet”
TIER IV partners with Arm on new automotive technologies
TOKYO, March 13, 2024 /PRNewswire/ — TIER IV, a pioneer in open-source autonomous driving (AD) technology, is excited to be collaborating with Arm, a leader in semiconductor and software design, as a key AD end-application partner. A group of industry leaders, including TIER IV and the Autowa